Why Beacon?
Discover how Beacon DDR enables data-driven insight that will accelerate your DDR drug development decisions
- Validate DDR asset potential with insights on competitor programs, clinical outcomes, and market activity
- Explore DDR design strategies from repair pathways and synthetic lethality to emerging target investigations
- Benchmark your research with validated preclinical data, including publication summaries, and links to conference abstracts and posters
- Optimize clinical trial design by analyzing trial endpoints, outcomes, and regulatory precedents, to accelerate progression into the clinic
- Find the right partners in a competitive market, by tracking new companies, collaborations, and licensing deals, as they emerge
Join 24/25 top Pharma companies who use Beacon to accelerate and improve their drug development decisions.